Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders-Reference-Cited by-同舟云学术

Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

Published:2009-08 Issue:4 Volume:14 Page:187-197
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Cerny Jan¹,Trneny Marek²,Slavickova Alena²,Pytlik Robert²,Salkova Jana²,Valkova Veronika³,Liu Qin⁴,Houghton JeanMarie⁵,Klener Pavel²

Affiliation:

1. Department of MedicineDivision of Hematology and Oncology, University of Massachusetts, Worcester, MA, USA; 1st Department of Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech

2. 1st Department of Medicine1st Faculty of Medicine, Charles University, Prague, Czech

3. The Institute of Hematology and Blood Transfusion Prague, Czech

4. Department of Cancer BiologyUniversity of Massachusetts, Worcester, MA, USA

5. Department of Cancer BiologyUniversity of Massachusetts, Worcester, MA, USA; Department of Medicine, University of Massachusetts, Worcester, MA, USA

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/102453309X426227

Reference33 articles.

1. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia

2. Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma

3. Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

4. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma

5. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma;Oncology Letters;2010-07